 antibiotics GSK enzyme bacterial Wellcome Trust antibiotic resistance Bloomberg new-gen topoisomerase quinolones Defense Threat Reduction Agency GSK-299423 clinically proven researcher Michael Gwynn technology transfer structure drugs drug design R&D exodus Big Pharma biotech risk Tufts Medical Center Boston Hospital-acquired infections risk Dow Jones